BACKGROUND
Crixus BH3
We are a blank check company
incorporated on February 23, 2021 as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
We were initially incorporated under the name BH3 Acquisition Corp. and subsequently changed our name to Crixus BH3 Acquisition Company on July 21, 2021. We intend to effectuate our initial business combination (the Business
Combination) using cash from the proceeds of the IPO and the private placement of the private placement warrants, our capital stock, debt or a combination of cash, stock and debt.
Our registration statement for the IPO was declared effective on October 4, 2021. On October 7, 2021, we consummated the IPO of
23,000,000 units (the Units), which included the full exercise of the underwriters over-allotment option, at $10.00 per Unit, generating gross proceeds of $230,000,000, and incurring offering costs of approximately
$22.4 million.
Simultaneously with the closing of the IPO on October 7, 2021, we consummated the sale in a private placement
(the Private Placement) of an aggregate of 6,400,000 warrants (the Private Placement Warrants) at a price of $1.50 per Private Placement Warrant to our sponsor, generating proceeds of $9,600,000.
The Units began trading on October 5, 2021 on the Nasdaq Global Market (the Nasdaq) under the symbol BHACU.
Commencing on November 26, 2021, the shares of Class A common stock and warrants comprising the Units began separate trading on the Nasdaq under the symbols BHAC and BHACW, respectively. Those Units not separated
continue to trade on the Nasdaq under the symbol BHACU.
Our initial stockholders (including our anchor investors) currently
hold 5,750,000 founder shares. The founder shares will automatically convert into shares of our Class A common stock on the first business day following the completion of our initial business combination. Prior to our initial business
combination, only holders of founder shares will be entitled to vote on the election of directors.
Our anchor investors purchased an
aggregate of approximately 22,980,000 units in the IPO at the public offering price of $10.00. No anchor investor purchased more than 9.9% of the units offered. Upon the closing our IPO, our anchor investors owned, in the aggregate, approximately
79.9% of the outstanding shares of our common stock. In consideration of those purchases, our sponsor entered into an investment agreement with each of the anchor investors pursuant to which our sponsor sold an aggregate of 1,450,758 founder shares,
at the original purchase price of approximately $0.004 per share.
Upon the closing of the IPO and the Private Placement, $232,300,000
($10.10 per Unit) of the net proceeds of the sale of the Units in the IPO and of the Private Placement Warrants in the Private Placement were placed in the Trust Account with Continental Stock Transfer & Trust Company acting as trustee, and
invested only in U.S. government securities within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of an initial business
combination and (ii) the distribution of the Trust Account as described below.
The underwriters agreed to defer $8,050,000 of the
underwriting discounts and commissions until our consummation of an initial business combination.
On December 7, 2022 (following
approval by our stockholders at a special meeting), we effected (among other things) the December 2022 Amendment to extend the Initial Termination Date to the Existing Termination Date, provided that our sponsor (or its affiliates or designees)
provided that, in each case, our sponsor (or its affiliates or designees) provided to us an Extension Notice no later than five business days prior to an Existing Termination Date and deposited in the Trust Account a Deposit Amount in consideration
of our execution and delivery of a non-interest
20